LON:TED - Ted Baker Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: GBX 225
  • Forecasted Upside: 46.77 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
GBX 153.30
▼ -13.1 (-7.87%)
1 month | 3 months | 12 months
Get New Ted Baker Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TED and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TED

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
GBX 225
▲ +46.77% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Ted Baker in the last 3 months. The average price target is GBX 225, with a high forecast of GBX 225 and a low forecast of GBX 225. The average price target represents a 46.77% upside from the last price of GBX 153.30.

Buy

The current consensus among 2 contributing investment analysts is to buy stock in Ted Baker. This rating changed within the last month from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 1 sell ratings
12/22/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 1 sell ratings
3/21/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 1 sell ratings
6/19/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 1 sell ratings
9/17/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 1 sell ratings
12/16/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 1 sell ratings
3/16/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 1 sell ratings
5/15/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/14/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
6/14/2021Liberum CapitalReiterated RatingBuyGBX 225
i
5/24/2021Liberum CapitalReiterated RatingBuyGBX 225
i
5/5/2021Liberum CapitalReiterated RatingBuyGBX 225
i
7/21/2020Peel HuntReiterated RatingHold
i
7/21/2020Liberum CapitalReiterated RatingBuy
i
7/14/2020Liberum CapitalReiterated RatingBuy
i
6/26/2020Liberum CapitalReiterated RatingBuy
i
6/19/2020Liberum CapitalReiterated RatingBuy
i
6/3/2020The Goldman Sachs GroupLower Price TargetNeutralGBX 146.57 ➝ GBX 130
i
6/3/2020Royal Bank of CanadaLower Price TargetUnderperformGBX 300 ➝ GBX 140
i
5/29/2020Peel HuntReiterated RatingHold
i
3/24/2020Liberum CapitalReiterated RatingBuy
i
2/27/2020Liberum CapitalReiterated RatingUnder Review
i
2/13/2020Peel HuntReiterated RatingHold
i
2/5/2020Peel HuntReiterated RatingHold
i
1/29/2020Peel HuntReiterated RatingHold
i
1/22/2020Liberum CapitalReiterated RatingUnder Review
i
1/22/2020Peel HuntReiterated RatingHold
i
1/13/2020Royal Bank of CanadaDowngradeUnderperformGBX 440 ➝ GBX 300
i
1/10/2020Peel HuntReiterated RatingHold
i
12/18/2019Peel HuntReiterated RatingHold
i
12/16/2019HSBCLower Price TargetHoldGBX 465 ➝ GBX 345
i
12/13/2019The Goldman Sachs GroupLower Price TargetNeutralGBX 450 ➝ GBX 390
i
12/11/2019Panmure GordonReiterated RatingUnder Review
i
12/10/2019Peel HuntReiterated RatingHoldGBX 500 ➝ GBX 300
i
12/10/2019Liberum CapitalReiterated RatingUnder Review
i
12/2/2019Peel HuntReiterated RatingHold
i
12/2/2019Liberum CapitalReiterated RatingUnder Review
i
11/15/2019Royal Bank of CanadaLower Price TargetSector PerformerGBX 900 ➝ GBX 440
i
11/7/2019The Goldman Sachs GroupLower Price TargetNeutralGBX 600 ➝ GBX 450
i
10/3/2019Peel HuntReiterated RatingHoldGBX 950
i
10/3/2019Peel HuntReiterated RatingHoldGBX 950
i
10/3/2019Liberum CapitalReiterated RatingUnder Review
i
8/28/2019Peel HuntReiterated RatingHold
i
8/28/2019Liberum CapitalReiterated RatingBuyGBX 1,280
i
8/22/2019Peel HuntReiterated RatingHoldGBX 950
i
8/22/2019Peel HuntReiterated RatingHoldGBX 950
i
8/16/2019Liberum CapitalReiterated RatingBuy
i
7/2/2019Liberum CapitalReiterated RatingBuy
i
6/26/2019Royal Bank of CanadaDowngradeSector PerformerGBX 1,900 ➝ GBX 900
i
6/21/2019Liberum CapitalReiterated RatingBuyGBX 1,280
i
6/20/2019The Goldman Sachs GroupLower Price TargetNeutralGBX 1,700 ➝ GBX 890
i
6/11/2019Liberum CapitalLower Price TargetBuyGBX 2,300 ➝ GBX 1,280
i
6/10/2019Peel HuntReiterated RatingHoldGBX 1,400 ➝ GBX 950
i
5/22/2019The Goldman Sachs GroupLower Price TargetNeutralGBX 1,800 ➝ GBX 1,700
i
4/11/2019Peel HuntReiterated RatingHold
i
4/10/2019Liberum CapitalReiterated RatingBuy
i
4/9/2019Jefferies Financial GroupDowngradeHold
i
3/22/2019Royal Bank of CanadaLower Price TargetOutperformGBX 2,000 ➝ GBX 1,900
i
3/22/2019The Goldman Sachs GroupDowngradeNeutralGBX 2,150 ➝ GBX 1,800
i
3/21/2019Liberum CapitalLower Price TargetBuyGBX 2,800 ➝ GBX 2,300
i
3/21/2019Peel HuntReiterated RatingHold
i
3/5/2019Peel HuntReiterated RatingHold
i
3/4/2019Jefferies Financial GroupReiterated RatingHoldGBX 1,950
i
3/1/2019HSBCReiterated RatingBuy
i
2/27/2019Peel HuntReiterated RatingHold
i
2/27/2019Liberum CapitalLower Price TargetBuyGBX 3,100 ➝ GBX 2,800
i
2/4/2019Liberum CapitalReiterated RatingBuy
i
1/10/2019HSBCUpgradeBuyGBX 1,450 ➝ GBX 2,215
i
1/9/2019Peel HuntReiterated RatingHold
i
1/9/2019Liberum CapitalReiterated RatingBuyGBX 3,100
i
1/7/2019Royal Bank of CanadaLower Price TargetOutperformGBX 2,500 ➝ GBX 2,000
i
1/3/2019Peel HuntReiterated RatingHold
i
12/7/2018The Goldman Sachs GroupLower Price TargetBuyGBX 2,750 ➝ GBX 2,000
i
12/7/2018Jefferies Financial GroupUpgradeBuy
i
12/6/2018Peel HuntDowngradeHold
i
12/5/2018HSBCDowngradeHold
i
12/5/2018Liberum CapitalReiterated RatingBuy
i
11/21/2018HSBCReiterated RatingBuy
i
11/2/2018Peel HuntReiterated RatingAdd
i
10/18/2018Peel HuntReiterated RatingAdd
i
10/15/2018Royal Bank of CanadaLower Price TargetOutperformGBX 3,000 ➝ GBX 2,500
i
10/5/2018BarclaysLower Price TargetEqual weightGBX 2,550 ➝ GBX 2,350
i
10/4/2018Peel HuntReiterated RatingAddGBX 2,800 ➝ GBX 2,400
i
10/4/2018Liberum CapitalLower Price TargetBuyGBX 3,300 ➝ GBX 3,100
i
9/10/2018Liberum CapitalReiterated RatingBuy
i
8/24/2018Peel HuntUpgradeAdd
i
8/20/2018Liberum CapitalReiterated RatingBuy
i
7/10/2018HSBCInitiated CoverageBuyGBX 2,900
i
6/22/2018Liberum CapitalReiterated RatingBuy
i
6/13/2018BarclaysLower Price TargetEqual weightGBX 2,700 ➝ GBX 2,550
i
6/12/2018Canaccord GenuityLower Price TargetBuyGBX 3,115 ➝ GBX 3,041
i
6/12/2018Peel HuntReiterated RatingHoldGBX 3,000 ➝ GBX 2,800
i
6/12/2018Liberum CapitalReiterated RatingBuyGBX 3,300
i
4/24/2018Liberum CapitalReiterated RatingBuyGBX 3,300
i
4/10/2018The Goldman Sachs GroupUpgradeBuyGBX 3,250
i
3/22/2018Stifel NicolausReiterated RatingBuyGBX 3,250
i
3/22/2018Peel HuntReiterated RatingHoldGBX 3,000
i
3/22/2018Liberum CapitalReiterated RatingBuyGBX 3,300
i
3/7/2018Liberum CapitalReiterated RatingBuyGBX 3,300
i
2/2/2018Liberum CapitalReiterated RatingBuyGBX 3,300
i
2/1/2018Peel HuntReiterated RatingHoldGBX 3,000
i
1/17/2018Liberum CapitalReiterated RatingBuyGBX 3,300
i
1/10/2018Peel HuntBoost Price TargetHoldGBX 2,750 ➝ GBX 3,000
i
1/10/2018Liberum CapitalBoost Price TargetBuyGBX 3,100 ➝ GBX 3,300
i
1/2/2018Jefferies Financial GroupReiterated RatingBuyGBX 3,000
i
12/6/2017BarclaysInitiated CoverageEqual WeightGBX 2,700
i
12/5/2017Peel HuntReiterated RatingHoldGBX 2,750
i
11/16/2017Liberum CapitalReiterated RatingBuyGBX 3,100
i
11/16/2017Peel HuntReiterated RatingHoldGBX 2,750
i
10/11/2017Jefferies Financial GroupBoost Price TargetBuyGBX 2,900 ➝ GBX 3,100
i
10/10/2017Peel HuntReiterated RatingHoldGBX 2,750
i
10/10/2017Liberum CapitalReiterated RatingBuyGBX 3,100
i
10/3/2017Liberum CapitalReiterated RatingBuyGBX 3,100
i
9/15/2017Peel HuntReiterated RatingHoldGBX 2,750
i
9/13/2017Liberum CapitalReiterated RatingBuyGBX 3,100
i
7/7/2017Liberum CapitalReiterated RatingBuyGBX 3,100
i
6/27/2017Royal Bank of CanadaReiterated RatingOutperformGBX 2,800
i
6/19/2017Liberum CapitalReiterated RatingBuyGBX 3,100
i
6/14/2017Jefferies Financial GroupBoost Price TargetBuyGBX 2,820 ➝ GBX 2,900
i
6/13/2017Peel HuntLower Price TargetHoldGBX 3,100 ➝ GBX 2,750
i
6/13/2017Liberum CapitalReiterated RatingBuyGBX 3,100
i
6/9/2017Royal Bank of CanadaInitiated CoverageOutperformGBX 2,800
i
4/19/2017Liberum CapitalReiterated RatingBuyGBX 3,100
i
3/27/2017Canaccord GenuityReiterated RatingBuyGBX 3,115
i
3/24/2017The Goldman Sachs GroupLower Price TargetBuyGBX 3,140 ➝ GBX 3,100
i
3/24/2017Jefferies Financial GroupReiterated RatingBuyGBX 2,820
i
3/23/2017Peel HuntReiterated RatingHoldGBX 3,100
i
3/23/2017Liberum CapitalReiterated RatingBuyGBX 3,100
i
1/12/2017Panmure GordonReiterated RatingSell
i
1/11/2017Peel HuntReiterated RatingHoldGBX 3,100
i
1/11/2017Liberum CapitalReiterated RatingBuyGBX 3,100
i
1/6/2017Panmure GordonReiterated RatingSell
i
11/17/2016Panmure GordonReiterated RatingSell
i
11/17/2016Canaccord GenuityReiterated RatingBuyGBX 3,571
i
11/17/2016Liberum CapitalReiterated RatingBuyGBX 3,100
i
11/17/2016Peel HuntReiterated RatingHoldGBX 3,100
i
10/13/2016The Goldman Sachs GroupReiterated RatingBuyGBX 3,140
i
10/11/2016Canaccord GenuityReiterated RatingBuyGBX 3,571
i
10/11/2016Jefferies Financial GroupReiterated RatingBuyGBX 2,820
i
10/11/2016Liberum CapitalReiterated RatingBuyGBX 3,100
i
10/11/2016Peel HuntReiterated RatingHoldGBX 3,100
i
9/23/2016The Goldman Sachs GroupReiterated RatingBuyGBX 3,500 ➝ GBX 2,925
i
9/9/2016BNP ParibasInitiated CoverageOutperformGBX 3,500
i
9/6/2016The Goldman Sachs GroupReiterated RatingBuyGBX 3,500
i
8/2/2016Peel HuntReiterated RatingHoldGBX 3,100
i
7/13/2016Panmure GordonReiterated RatingSell
i
7/5/2016Jefferies Financial GroupLower Price TargetBuyGBX 3,000 ➝ GBX 2,820
i
7/5/2016Liberum CapitalReiterated RatingBuyGBX 3,100
i
6/27/2016The Goldman Sachs GroupReiterated RatingBuyGBX 4,300
i
6/14/2016Canaccord GenuityReiterated RatingBuyGBX 3,571
i
6/14/2016Peel HuntReiterated RatingHoldGBX 3,100
i
(Data available from 6/14/2016 forward)
Ted Baker logo
Ted Baker Plc engages in the design, wholesale, and retail of menswear, womenswear, and accessories under the Ted Baker brand in the United States, the United Kingdome, Europe, Canada, and South Africa. The company operates through three segments: Retail, Wholesale, and Licensing. It offers various collections, including global, phormal, endurance, accessories, bedding, children's wear, eyewear, footwear, fragrance and skin wear, gifting and stationery, jewelry, lingerie and sleepwear, luggage, neckwear, rugs, suiting, technical accessories, tiles, and watches. The company distributes its products through retail stores, concessions, independent retailers, and department stores, as well as through its e-commerce business. As of January 25, 2020, it operated 88 own stores, 306 concessions, and 34 outlets. Ted Baker Plc was founded in 1987 and is headquartered in London, the United Kingdom.
Read More

Today's Range

Now: GBX 153.30
150.13
176.90

50 Day Range

MA: GBX 169.20
123.80
212.40

52 Week Range

Now: GBX 153.30
59.57
217.60

Volume

2,575,227 shs

Average Volume

785,585 shs

Market Capitalization

£283.01 million

P/E Ratio

N/A

Dividend Yield

12.20%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Ted Baker?

The following sell-side analysts have issued reports on Ted Baker in the last year: Liberum Capital, and Peel Hunt.
View the latest analyst ratings for TED.

What is the current price target for Ted Baker?

1 Wall Street analysts have set twelve-month price targets for Ted Baker in the last year. Their average twelve-month price target is GBX 225, suggesting a possible upside of 46.8%. Liberum Capital has the highest price target set, predicting TED will reach GBX 225 in the next twelve months. Liberum Capital has the lowest price target set, forecasting a price of GBX 225 for Ted Baker in the next year.
View the latest price targets for TED.

What is the current consensus analyst rating for Ted Baker?

Ted Baker currently has 1 hold rating and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe TED will outperform the market and that investors should add to their positions of Ted Baker.
View the latest ratings for TED.

What other companies compete with Ted Baker?

How do I contact Ted Baker's investor relations team?

Ted Baker's physical mailing address is Ugly Brown Bldg, 6a St. Pancras Way, LONDON, NW1 0TB, United Kingdom. The company's listed phone number is +44-20-72554800. The official website for Ted Baker is www.tedbakerplc.com.